Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7RL1M
|
|||
| Drug Name |
Triplex
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Cytomegalovirus infection [ICD-11: 1D82] | Phase 2 | [1] | |
| Company |
HeloCyte
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05099965) Phase II, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex?), in Adults With Both Human Immunodeficiency Virus (HIV)-1 and CMV Who Are on Potent Combination ART With Conserved Immune Function. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.